These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 21805293)
21. Protective effects of TRH and its analogues against various cytotoxic agents in retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells. Jaworska-Feil L; Jantas D; Leskiewicz M; Budziszewska B; Kubera M; Basta-Kaim A; Lipkowski AW; Lason W Neuropeptides; 2010 Dec; 44(6):495-508. PubMed ID: 20869113 [TBL] [Abstract][Full Text] [Related]
22. Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage. Lev N; Melamed E; Offen D Neurosci Lett; 2006 May; 399(1-2):27-32. PubMed ID: 16584840 [TBL] [Abstract][Full Text] [Related]
23. Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: therapeutic implications for Parkinson's disease. Tai KK; Truong DD J Neurosci Res; 2002 Aug; 69(4):559-66. PubMed ID: 12210849 [TBL] [Abstract][Full Text] [Related]
24. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway. Jalava A; Akerman K; Heikkilä J J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723 [TBL] [Abstract][Full Text] [Related]
25. Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells. Ikeda Y; Tsuji S; Satoh A; Ishikura M; Shirasawa T; Shimizu T J Neurochem; 2008 Dec; 107(6):1730-40. PubMed ID: 19014378 [TBL] [Abstract][Full Text] [Related]
26. Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis. Klintworth H; Newhouse K; Li T; Choi WS; Faigle R; Xia Z Toxicol Sci; 2007 May; 97(1):149-62. PubMed ID: 17324951 [TBL] [Abstract][Full Text] [Related]
27. FTIR spectroscopy studies on the bioprotective effectiveness of trehalose on human hemoglobin aqueous solutions under 50 Hz electromagnetic field exposure. Magazù S; Calabrò E; Campo S J Phys Chem B; 2010 Sep; 114(37):12144-9. PubMed ID: 20799749 [TBL] [Abstract][Full Text] [Related]
28. Dual effects of alpha-synuclein on neurotoxicity induced by low dosage of rotenone are dependent on exposure time in dopaminergic neuroblastoma cells. Lu L; Gu L; Liang Y; Sun X; Duan C; Yang H Sci China Life Sci; 2010 May; 53(5):590-7. PubMed ID: 20596942 [TBL] [Abstract][Full Text] [Related]
29. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease. Verma R; Nehru B Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462 [TBL] [Abstract][Full Text] [Related]
30. Acetyl-L-carnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy. Zaitone SA; Abo-Elmatty DM; Shaalan AA Pharmacol Biochem Behav; 2012 Jan; 100(3):347-60. PubMed ID: 21958946 [TBL] [Abstract][Full Text] [Related]
31. Astrocytes protect MN9D neuronal cells against rotenone-induced oxidative stress by a glutathione-dependent mechanism. Cao Q; Wei LR; Lu LL; Zhao CL; Zhao HY; Yang H Sheng Li Xue Bao; 2007 Jun; 59(3):253-9. PubMed ID: 17579777 [TBL] [Abstract][Full Text] [Related]
32. Protective effect of histamine H2 receptor antagonist ranitidine against rotenone-induced apoptosis. Park HJ; Kim HJ; Park HK; Chung JH Neurotoxicology; 2009 Nov; 30(6):1114-9. PubMed ID: 19723537 [TBL] [Abstract][Full Text] [Related]
33. Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cells. Watabe M; Nakaki T J Pharmacol Exp Ther; 2004 Dec; 311(3):948-53. PubMed ID: 15280438 [TBL] [Abstract][Full Text] [Related]
34. [Overexpression of alpha-synuclein in SH-SY5Y cells partially protected against oxidative stress induced by rotenone]. Liu YY; Zhao HY; Zhao CL; Duan CL; Lu LL; Yang H Sheng Li Xue Bao; 2006 Oct; 58(5):421-8. PubMed ID: 17041725 [TBL] [Abstract][Full Text] [Related]
35. An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells. Shamoto-Nagai M; Maruyama W; Kato Y; Isobe K; Tanaka M; Naoi M; Osawa T J Neurosci Res; 2003 Nov; 74(4):589-97. PubMed ID: 14598303 [TBL] [Abstract][Full Text] [Related]
36. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine. Moussa CE; Wersinger C; Tomita Y; Sidhu A Biochemistry; 2004 May; 43(18):5539-50. PubMed ID: 15122920 [TBL] [Abstract][Full Text] [Related]
37. Biomolecular investigation of human substantia nigra in Parkinson's disease by synchrotron radiation Fourier transform infrared microspectroscopy. Szczerbowska-Boruchowska M; Dumas P; Kastyak MZ; Chwiej J; Lankosz M; Adamek D; Krygowska-Wajs A Arch Biochem Biophys; 2007 Mar; 459(2):241-8. PubMed ID: 17274943 [TBL] [Abstract][Full Text] [Related]
38. Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+) -induced cellular model of Parkinson's disease. Cai X; Jia H; Liu Z; Hou B; Luo C; Feng Z; Li W; Liu J J Neurosci Res; 2008 Dec; 86(16):3622-34. PubMed ID: 18709653 [TBL] [Abstract][Full Text] [Related]
39. Failure of FK506 (tacrolimus) to alleviate apomorphine-induced circling in rat Parkinson model in spite of some cytoprotective effects in SH-SY5Y dopaminergic cells. Manáková S; Singh A; Kääriäinen T; Taari H; Kulkarni SK; Männistö PT Brain Res; 2005 Mar; 1038(1):83-91. PubMed ID: 15748876 [TBL] [Abstract][Full Text] [Related]
40. Development of a high-throughput screening assay for cytoprotective agents in rotenone-induced cell death. Yoon IS; Au Q; Barber JR; Ng SC; Zhang B Anal Biochem; 2010 Dec; 407(2):205-10. PubMed ID: 20705047 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]